BioAffinity Technologies Inc (BIAF) concluded trading on Thursday at a closing price of $0.51, with 0.46 million shares of worth about $0.24 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -73.99% during that period and on April 17, 2025 the price saw a gain of about 9.67%. Currently the company’s common shares owned by public are about 15.58M shares, out of which, 11.04M shares are available for trading.
Stock saw a price change of -8.05% in past 5 days and over the past one month there was a price change of 79.76%. Year-to-date (YTD), BIAF shares are showing a performance of -43.41% which decreased to -81.80% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.24 but also hit the highest price of $3.16 during that period. The average intraday trading volume for BioAffinity Technologies Inc shares is 9.53 million. The stock is currently trading 0.14% above its 20-day simple moving average (SMA20), while that difference is down -4.94% for SMA50 and it goes to -59.84% lower than SMA200.
BioAffinity Technologies Inc (NASDAQ: BIAF) currently have 15.58M outstanding shares and institutions hold larger chunk of about 2.94% of that.
The stock has a current market capitalization of $9.40M and its 3Y-monthly beta is at 1.94. It has posted earnings per share of -$0.74 in the same period. It has Quick Ratio of 0.86 while making debt-to-equity ratio of 0.58. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BIAF, volatility over the week remained 13.41% while standing at 26.02% over the month.
Stock’s fiscal year EPS is expected to rise by 40.00% while it is estimated to increase by 53.33% in next year.
